Predicine, a global molecular insights company, announces the introduction of PredicineCOMPLETE™, the organization’s most comprehensive next-generation liquid biopsy solution that provides genome-wide, genomic and epigenomic insights to capture the mutational landscape and the...
Read More »EXOSOME NEWS
Early diagnosis tool for childhood kidney disease
New technique can detect damage to children’s kidneys earlier than current testsEarly diagnosis of chronic kidney disease (CKD) is key to managing progression of the disease. A new technique...
Read More »Exosome biogenesis – machinery, regulation, and therapeutic implications in cancer
Exosomes are well-known key mediators of intercellular communication and contribute to various physiological and pathological processes. Their biogenesis involves four key steps, including cargo sorting, MVB formation and maturation...
Read More »Serpin-loaded extracellular vesicles promote tissue repair in a mouse model of impaired wound healing
Chronic metabolic diseases such as diabetes are characterized by delayed wound healing and a dysregulation of the inflammatory phase of wound...
Read More »Exosome RNA sequencing as a tool in the search for cancer biomarkers
Numerous noninvasive methods are currently being used to determine biomarkers for diseases such as cancer. However, these methods are not always precise and reliable. Thus, there is an unmet need ...
Read More »Single-step and highly sensitive imaging of exosomal PD-L1 through branched DNA nanostructures
Exosomal PD-L1 plays a critical role in tumor progress and immunotherapy. However, accurately analyzing exosomal PD-L1 is greatly limited by the small-sized and free-floating nature of exosomes and...
Read More »Antenatal administration of amniotic fluid stem cell extracellular vesicles rescues development
Antenatal administration of amniotic fluid stem cell extracellular vesicles rescues pulmonary vascular development in experimental congenital diaphragmatic hernia – Presented by Augusto Zani
Read More »Exosome scientist recognized with Canada’s top award for early-career cardiovascular researchers
Heart failure is a growing problem. According to the Heart and Stroke Foundation, an estimated 750,000 Canadians live with heart failure and an additional...
Read More »Exosomes loaded with ultrasmall Pt nanoparticles: a novel low-toxicity alternative to cisplatin
Platinum nanoparticles have been demonstrated to have excellent anticancer properties. However, because of the lack of specificity they must be...
Read More »MDimune acquires intellectual property and partners with Ewha Womans University Medical Center to develop inflammatory bowel diseases therapeutics
MDimune, Inc., a Korean biotech company developing BioDrone™ platform technology based on cell-derived vesicles (CDVs), announced a business agreement with Ewha Womans University Medical Center (EUMC) and acquisition of IP from EUMC to...
Read More »Jobs
-
PhD position available – development of milk extracellular vesicles for therapeutic applications
We aim to test several hypothesises to further progress cow milk EVs application as a treatment for human digestive tract diseases and anomalies...
Read More » -
PhD research scholarship available: Exosomes as biomarkers for liver disease
-
Post-doc position available – extracellular vesicles biology
-
PhD project available – investigating the structure of extracellular vesicles and budded virus in baculovirus replication
-
Post-doc position available – microbiology and immunology
Industry News
-
Creative Biolabs Catches Wind of Stem Cell-Derived Exosome Therapeutics in Stroke
Considering a recently featured article by NIH introducing the therapeutic effects of NSC-derived exosomes in cerebral ischemia, Creative Biolabs updates its service portfolio related to stem cell-derived exosomes. Stroke often ...
Read More » -
Evox Therapeutics granted key US exosome purification patent
-
ExoCoBio granted first plant stem cell-derived exosome patent in the US
-
NurExone granted US patent for technology and drug composition of Exo-PTEN, designed for treating acute spinal cord injuries
-
Mursla Bio to showcase its novel tissue-specific extracellular vesicle isolation technology at ISEV2023